Form 4 for MNPR Monopar Therapeutics
Accepted 2022-11-16 00:00:00 ET · period of report 2022-11-14 · accession 0001863624-22-000001 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-11-16 | 2022-11-14+ | MNPR | Cittadine Andrew | COO | P - Purchase | $3.09 | +16.1K | 24.2K | +196% | +$49.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-14 | P | A | 6,053 | $3.00 | 14,238 | D | — | — | |
| 2 | Common | Common Stock | 2022-11-15 | P | A | 10,000 | $3.15 | 24,238 | D | — | — |